European Archives - Page 631 of 1062 - European Medical Journal

Review of the American Society of Hematology (ASH) Congress 2019

The City Beautiful” proved to be an appropriate nickname for Orlando, Florida, USA, where the sun shined as >30,000 attendees flocked to attend this…

Dr Emanuele Angelucci

Chair, Hematology and Cellular Therapy Unit, Ospedale Policlinico San Martino; Transplant Program Director, Istituto di Ricovero e Cura a…

EMJ

Dr Dimitar Efremov

ASH 2019 Interviews

We spoke to Prof Theresa L. Coetzer, the Chair of the ASH International Members Committee, and Dr Pierluigi Porcu, the Chair of ASH Foundation…

EMJ Hematology US 1.1 2020

Novel CD33 Antibodies Reveal CD33 Splicing Polymorphism Variant Localisation and Therapeutic Implications

Acute myeloid leukaemia (AML) is a heterogeneous haematologic malignancy characterised by dysfunctional proliferation and differentiation of myeloid progenitor cells.

EMJ Hematology US 1.1 2020

Therapeutic Options in Myelodysplastic Syndromes Following Hypomethylating Agent Failure

Myelodysplastic syndromes (mds) are a heterogeneous group of disorders defined by ineffective haematopoiesis and clonal instability with risk of…

EMJ

Dr Utkarsh Acharya

Program Director, Hematology-Oncology Fellowship Program, DFCI (Dana-Farber Cancer Institute)/SEMC(St Elizabeth’s Medical Center)…

EMJ Hematology US 1.1 2020

Reed Sternberg-Like Cells in an Aggressive Lymphoma: Report of a Rare Case and Review of Literature

In low-grade B-cell lymphomas, Reed Sternberg (RS)-like cells can be seen in follicular lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, and marginal zone lymphoma.

EMJ Hematology US 1.1 2020

Safety and Efficacy of 1,020 mg Total Dose Infusion of Ferumoxytol in a Veterans Health System

Ferumoxytol is an intravenous (IV) formulation of iron that can be infused quickly, making it a convenient choice.

EMJ

Dr David Gómez Almaguer